Search
for
Sort by
Research 31–60 of 1000+
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- Practical Geriatrics: Men's Sexual Health After Midlife
- Topical Minoxidil 5% Induced Male Sexual Dysfunction
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- PCPT Results Could Affect Trial on Testosterone Replacement
- Finasteride and sexual side effects
- Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
- Endocrinology
- Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients
- How routine pharmacovigilance failed to identify finasteride’s persistent sexual side effects
- Current Literature Review
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- The Role of Medical Language in Changing Public Perceptions of Illness
- Clinical Pearls in Men's Health
- The nocebo effect: A clinicians guide
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Lifestyle Drugs
- Red ginseng monograph
- The placebo effect and randomized trials: analysis of conventional medicine
- A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer
- 5α‐Reductase Inhibitors
- Clinical review of ejaculatory dysfunction
- Andrology
- Sexual Dysfunction in Alopecia Areata: A Systematic Review
- Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Synopsis: 2005 Annual Meeting of the American Society of Andrology